Funded Tech Companies
GlycoMimetics
Operating out of Gaithersburg, GlycoMimetics has funding from Genzyme Ventures, Novartis Venture Fund and Anthem Capital.
Company Overview
Company Name
GlycoMimetics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
9708 Medical Center Dr. 250
Gaithersburg, MD 20850
USA
Gaithersburg, MD 20850
USA
Phone
Website
Email Address
Company Background Information
Overview
GlycoMimetics is a clinical-stage biotechnology company utilizing novel and proprietary glycobiology technology to develop treatments for diseases, particularly where there is high unmet need.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
10/20/2009
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Rachel King
Chief Financial Officer
Brian Hahn
Chief Medical Officer
Helen Thackray
Chief Scientific Officer
John Magnani
VP - Bus. Development
Armand Girard
VP - Operations
Henry Flanner
Company Investors
- Genzyme Ventures (Rachel King)
- Novartis Venture Fund
- Anthem Capital
- New Enterprise Associates (James Barrett)
- Alliance Technology Ventures
- Novartis BioVenture Fund (Rachel King)
- Anthem Capital (William Gust)
- Alliance Technology Ventures (Michael Henos)
- Maryland Department of Business and Economic Development
Browse more funded tech companies:
Share this article
About Our VC Deals Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs